METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA

Clinical trials for METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double attack on advanced prostate cancer: radiation meets immune vaccine

Disease control Recruiting now

This early-stage study is testing if combining two different treatments is safe and works better than one alone for advanced prostate cancer. One treatment is a targeted radiation drug that seeks out and kills cancer cells. The other is a personalized vaccine designed to train th…

Matched conditions: METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA

Get alerted when new METASTATIC CASTRATION-RESISTANT PROSTATE ADENOCARCINOMA trials appear

Double attack on advanced prostate cancer: radiation meets immune vaccine